The Linux Foundation Hosts Project to Decentralize and Accelerate Drug Development for Rare Genetic Diseases
SAN FRANCISCO, March 31, 2021 /PRNewswire/ -- The Linux Foundation, the nonprofit organization enabling mass innovation through open source, and the OpenTreatments Foundation, which enables treatments for rare genetic diseases regardless of rarity and geography, today announced the RareCamp software project will be hosted at the Linux Foundation. The Project will provide the source code and open governance for the OpenTreatments software platform to enable patients to create gene therapies for rare genetic diseases.
The project is supported by individual contributors, as well as collaborations from companies that include Baylor College of Medicine, Castle IRB, Charles River, Columbus Children's Foundation, GlobalGenes, Odylia Therapeutics, RARE-X and Turing.com.
"OpenTreatments and RareCamp decentralize drug development and empowers patients, families and other motivated individuals to create treatments for diseases they care about. We will enable the hand off of these therapies to commercial, governmental and philanthropic entities to ensure patients around the world get access to the therapies for the years to come," said Sanath Kumar Ramesh, founder of the OpenTreatments Foundation and creator of RareCamp.
There are 400 million patients worldwide affected by more than 7,000 rare diseases, yet treatments for rare genetic diseases are an underserved area. More than 95 percent of rare diseases do not have an approved treatment, and new treatments are estimated to cost more than $1 billion.
"If it's not yet commercially viable to create treatments for rare diseases, we will take this work into our own hands with open source software and community collaboration is the way we can do it," said Ramesh.
"OpenTreatments and RareCamp really demonstrate how technology and collaboration can have an impact on human life," said Brett Andrews, RareCamp contributor and software engineer at Vendia. "Sanath's vision is fueled with love for his son, technical savvy and the desire to share what he's learning with others who can benefit. Contributing to this project was an easy decision."
"Today we are seeing the unique convergences of transformative AAV gene therapy technology with the power of open source platform capability in an effort to 1) accelerate, 2) facilitate, and 3) efficiently disseminate novel gene therapy drugs to the long overdue unmet medical needs of the orphan disease community. It is humbling and exciting at the same time to be an integral part of this amazing initiative," said Dr. Jude Samulski, founder of Columbus Children's Foundation.
"OpenTreatments Foundation and RareCamp really represent exactly why open source and collaboration are so powerful - because they allow all of us to do more together than any one of us," said Mike Dolan, executive vice president and GM of Projects at the Linux Foundation. "We're honored to be able to support this community and are both confident and inspired about its impact on human lives."
"At Turing we believe in both the power of software to change the world and in the ability of our boundaryless economy to solve the global challenges we face," said Jonathan Siddharth, co-founder and CEO of Turing.com. "So we are pleased to contribute top engineering talent to OpenTreatments in support of their work to decentralize and accelerate drug development for rare genetic diseases, regardless of rarity or geography. Viewing ourselves as part of a boundaryless ecosystem and leveraging that ecosystem to tap into talented developers regardless of geography is the way to create the breakthrough treatments needed for such rare genetic diseases."
"Recently, patient groups have risen as the primary driving force behind drug development for rare diseases. The support provided by OpenTreatments to patient-led organizations will dramatically reduce both the time and cost of drug development, leading to more treatments reaching patients faster," said Dr. Ashley Winslow, Chief Scientific Officer of Odylia Therapeutics.
For more information and to contribute, please visit: OpenTreatments.org
About OpenTreatments Foundation
About the Linux Foundation
The Linux Foundation has registered trademarks and uses trademarks. For a list of trademarks of The Linux Foundation, please see our trademark usage page: https://www.linuxfoundation.org/trademark-usage. Linux is a registered trademark of Linus Torvalds.
View original content to download multimedia:http://www.prnewswire.com/news-releases/the-linux-foundation-hosts-project-to-decentralize-and-accelerate-drug-development-for-rare-genetic-diseases-301259760.html
SOURCE The Linux Foundation